Cannabis
Microdose Psychedelic Insights Announces Call for Speakers for Its Upcoming LSD Conference
Toronto, Ontario–(Newsfile Corp. – January 24, 2022) – Microdose Psychedelic Insights (“Microdose”) has opened its Call for Speakers for the LSD Molecular Masterclass, which will be held virtually on February 17 starting at 1:30pm EST. Presenting a scientific deep-dive into the dynamic field of LSD therapeutics, this event is a premier opportunity for speakers to share research, history, culture, medical benefits, and future of this crucial psychedelic compound.
The hundreds of attendees will have the opportunity to attend sessions on: Therapeutic Use of LSD in Psychiatry, Posology and Tolerance to Regression, Safety and Efficacy of Lysergic Acid Diethylamide Assisted Psychotherapy, LSD Microdosing, Effect of Lysergic Acid Diethylamide (LSD) on Learning, The Effects of LSD on Creativity – and more.
Those interested in presenting at LSD Molecular Masterclass may complete the application to become a speaker.
Headline sponsor of the event is MindBio Therapeutics a clinical stage drug development company conducting research into microdosing and medicinal use of psychedelic medicines to treat a range of debilitating mental health conditions.
Companies interested in sponsoring the event may reach out to Daniela Pauli for more details or book a call.
About Molecular Masterclass Conference Series
The Molecular Masterclass is a speaker series designed for deep dives into the world’s favorite psychoactive and psychedelic substances.
Previous events included: The Ketamine Conference, The Ibogaine Conference, The Mushroom Conference, and The MDMA Conference.
Additional information about LSD Masterclass, including registration details, speakers are available at https://microdose.buzz/lsd-conference.
NOTES TO EDITORS:
About Microdose Psychedelic Insights
Microdose Psychedelic Insights aims to unlock the potential of psychedelics through Industry events, market intelligence, original, evidence-based content, strategy and community. We enable and empower society at large to make better, more mindful decisions about psychedelics and its intersection with healthcare, medicine and personal growth. We work with the industry’s most influential stakeholders, some of the world’s best-known brands and an unrivalled network of scientists, researchers, analysts, innovators, investors and advisors.
Press Contact: [email protected]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/111232
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
transfer1 week ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis1 week ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
Cannabis1 week ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis1 week ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
CCELL®2 weeks ago
CCELL Launches Environmentally Conscious Eco Star AIO Vaporizer
-
Innocan4 days ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Cannabis3 days ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
Curaleaf4 days ago
Curaleaf Completes Acquisition of Northern Green Canada